Comparison of Immunogenicity of Alum and MF59-Like Adjuvant Inactivated SARS-CoV-2 Vaccines Against SARS-CoV-2 Variants in Elderly Mice
Viral Immunology · 2023
DOI: 10.1089/vim.2023.0041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viral Immunology, 2023. Verfasst von Shuang Bai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Center for Disease Prevention and Control, Beijing Research Center for Respiratory Infectious Diseases, Beijing, China. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Center for Disease Prevention and Control, Beijing Research Center for Respiratory Infectious Diseases, Beijing, China.
ORCID-Profile: Wei Zhao
Zitieren
APA
Bai, S., Kang, Y., Chen, W., Xie, H., Zhang, L., Lv, M., Wang, J., Wu, J., & Zhao, W. (2023). Comparison of Immunogenicity of Alum and MF59-Like Adjuvant Inactivated SARS-CoV-2 Vaccines Against SARS-CoV-2 Variants in Elderly Mice. Viral Immunology. https://doi.org/10.1089/vim.2023.0041
Vancouver
Bai S, Kang Y, Chen W, Xie H, Zhang L, Lv M, et al. Comparison of Immunogenicity of Alum and MF59-Like Adjuvant Inactivated SARS-CoV-2 Vaccines Against SARS-CoV-2 Variants in Elderly Mice. Viral Immunology. 2023. doi:10.1089/vim.2023.0041
BibTeX
@article{Bai2023,
author = {Bai, Shuang and Kang, Yanli and Chen, Weixin and Xie, Hui and Zhang, Lichi and Lv, Min and Wang, Jian and Wu, Jiang and Zhao, Wei},
title = {Comparison of Immunogenicity of Alum and MF59-Like Adjuvant Inactivated SARS-CoV-2 Vaccines Against SARS-CoV-2 Variants in Elderly Mice},
journal = {Viral Immunology},
year = {2023},
doi = {10.1089/vim.2023.0041}
}
EUVIMED